Clinical Trial Update: Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating IV NEPA (fosnetupitant/palonosetron) for prevention of chemotherapy-induced nausea and vomiting in pediatric cancer patients r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• NEPA (netupitant/palonosetron)

Snippet

Sponsor: Helsinn Healthcare SA | Conditions: Nausea and Vomiting Chemotherapy-Induced, Nausea Post Chemotherapy | Phase 2 | Status: RECRUITING